Intravenous Ibuprofen for Treatment of Post-Operative Pain: A Multicenter, Double Blind, Placebo-Controlled, Randomized Clinical Trial
Andrea Gago Martínez, Blanca Escontrela Rodriguez, Antonio Planas Roca, Alberto Martínez Ruiz, Andrea Gago Martínez, Blanca Escontrela Rodriguez, Antonio Planas Roca, Alberto Martínez Ruiz
Abstract
Background: Non-steroidal anti-inflammatory drugs are often used as components of multimodal therapy for postoperative pain management, but their use is currently limited by its side effects. The specific objective of this study was to evaluate the efficacy and safety of a new formulation of intravenous (IV) ibuprofen for the management of postoperative pain in a European population.
Methods and findings: A total of 206 patients from both abdominal and orthopedic surgery, were randomly assigned in 1:1 ratio to receive 800 mg IV-ibuprofen or placebo every 6 hours; all patients had morphine access through a patient controlled analgesia pump. The primary outcome measure was median morphine consumption within the first 24 hours following surgery. The mean±SEM of morphine requirements was reduced from 29,8±5,25 mg to 14,22±3,23 mg (p = 0,015) and resulted in a decrease in pain at rest (p = 0,02) measured by Visual Analog Scale (VAS) from mean±SEM 3.34±0,35 to 0.86±0.24, and also in pain during movement (p = 0,02) from 4.32±0,36 to 1.90±0,30 in the ibuprofen treatment arm; while in the placebo group VAS score at rest ranged from 4.68±0,40 to 2.12±0,42 and during movement from 5.66±0,42 to 3.38±0,44. Similar treatment-emergent adverse events occurred across both study groups and there was no difference in the overall incidence of these events.
Conclusions: Perioperative administration of IV-Ibuprofen 800 mg every 6 hours in abdominal surgery patient's decreases morphine requirements and pain score. Furthermore IV-Ibuprofen was safe and well tolerate. Consequently we consider appropriate that protocols for management of postoperative pain include IV-Ibuprofen 800 mg every 6 hours as an option to offer patients an analgesic benefit while reducing the potentially risks associated with morphine consumption.
Trial registration: EU Clinical Trials Register 2011-005007-33.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Carr DB, Gordas LC. Acute pain. Lancet. 1999;353: 2051–2058. 10.1016/S0140-6736(99)03313-9
- Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362: 1921–1928. 10.1016/S0140-6736(03)14966-5
- Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol. 2009;22: 588–593. 10.1097/ACO.0b013e328330373a
- Rosa-Díaz J, Navarrete-Zuazo V, Díaz-Mendiondo M. Aspectos básicos del dolor postoperatorio y la analgesia multimodal preventiva. Revista Mexicana de Anestesiología. 2014;37: 18–26.
- Ducharme J. Acute pain and pain control: State of the art. Ann Emerg Med. 2000;35: 592–603.
- Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative Pain Experience: Results from a National Survey Suggest Postoperative Pain Continues to Be Undermanaged. Anesth Analg. 2003;97: 534–540.
- Rathmell JP, Wu CL, Sinatra RS, Ballantyne JC, Ginsberg B, Gordon DB, et al. Acute post-surgical pain management: a critical appraisal of current practice. Reg Anesth Pain Med. 2006;31: 1–42. 10.1016/j.rapm.2006.05.002
- Singla N, Rock A, Pavliv L. A Multi-center, Randomized, Double-blind Placebo-controlled trial of Intravenous-Ibuprofen for Treatment of Pain in Post-operative orthopedic adult patients. Pain Med. 2010;11: 1284–1293. 10.1111/j.1526-4637.2010.00896.x
- Southworth S, Peters J, Rock A, Pavliv L. A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Intravenous Ibuprofen 400 and 800 mg every 6 hours in the Management of Postoperative Pain. Clin Ther. 2009;31: 1922–1935. 10.1016/j.clinthera.2009.08.026
- Sinatra RS, Jahr JS. Multimodal management of acute pain: the role of IV NSAIDs. Anesthesiology News, Special Report. 2011;37: 1–8.
- Woolf CJ, Chong MS. Preemptive analgesia: treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993;77: 362–379.
- Gottschalk A, Smith DS. New concepts in acute pain therapy: preemptive analgesia. Am Fam Physician. 2001;63: 1979–1984.
- Kroll PB, Meadows L, Rock A, Pavliv L. A multicenter, randomized, double blind, placebo-controlled trial of intravenous ibuprofen (IV-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. 2011;11: 23–32. 10.1111/j.1533-2500.2010.00402.x
- Kroll PB. Intravenous ibuprofen for postoperative pain. Pain Manag. 2012; 2:47–54. 10.2217/pmt.11.68
- Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61:277–284. 10.1016/0304-3959(94)00178-H
- Vadivelu N, Mitra S, Narayan D. Recent Advances in Postoperative Pain Management. Yale J Biol Med. 2010;83: 11–25. PMCID: PMC2844689.
- Voscopoulos C, Lema M. When does acute pain become chronic? BJA. 2010;105(1): i69–i85. 10.1093/bja/aeq323
- Kehlet H, Dahl JB. The Value of "Multimodal" or "Balanced Analgesia" in Postoperative Pain Treatment. Anesth Analg. 1993;77: 1048–1056.
- Max MB, Donovan M, Miaskowski CA, Ward SE, Gordon D, Bookbinder M, et al. Quality Improvement Guidelines for the Treatment of Acute Pain and Cancer Pain. JAMA. 1995;274: 1874–1880. 10.1001/jama.1995.03530230060032
- Dihle A, Helseth S, Paul SM, Miaskowski C. The exploration of the establishment of cut points to categorize the severity of acute postoperative pain. Clin J Pain. 2006;22: 617–624. 10.1097/01.ajp.0000210905.57546.c1
- Bookstaver PB, Miller AD, Rudisill CN, Norris LB. Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. J Pain Res. 2010;3: 67–79.
- Budd K. Pain management: is opioid immunosuppression a clinical problem? Biomedicine & Pharmacotherapy. 2006;60: 310–317. 10.1016/j.biopha.2006.06.015
- Shilling AM, Tiouririne M. Perioperative Morphine and Cancer Recurrence In: Parat MO, eds. Morphine and Metastasis. Dordrecht: Springer; 2013. pp. 123–142. 10.1007/978-94-007-5678-6_9
- Smith H, Bruckenthal P. Implications of Opioid Analgesia for Medically Complicated Patients. Drugs & Aging. 2010;27: 417–433. 10.2165/11536540-000000000-00000
- Angst MS, Clark JD. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology. 2006;104: 570–587.
- Raffa R, Pergolizzi J. Opioid-Induced Hyperalgesia: Is It Clinically Relevant for the Treatment of Pain Patients? Pain Management Nursing. 2013;14: 67–83. 10.1016/j.pmn.2011.04.002
- Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse Events Associated With Postoperative Opioid Analgesia: A Systematic Review. J Pain. 2002;3: 159–180. 10.1054/jpai.2002.123652
- Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: a review. Can J Anaesth. 2004;51: 326–341.
- Candiotti KA, Birnbach DJ, Lubarsky DA, Nhuch F, Kamat A, Koch WH, et al. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Anesthesiology. 2005;102: 543–549. 10.1097/01.sa.0000228088.73854.04
- Brinkmann A, Seeling W, Wolf CF, Kneitinger E, Vogt N, Steinbach G, et al. Ibuprofen does not impair renal function in patients undergoing infrarenal aortic surgery with epidural anesthesia. Intensive Care Med. 1998;24: 322–328. 10.1007/s001340050574
- Macintyre PE, Jarvis DA. Age is the best predictor of postoperative morphine requirements. Pain. 1996;64: 357–364. 10.1016/0304-3959(95)00128-X
- Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, Trégouet D, et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther. 2006;79: 316–324. 10.1016/j.clpt.2006.01.007
Source: PubMed